Effect of diet‐induced obesity or type 1 or type 2 diabetes on corneal nerves and peripheral neuropathy in C57Bl/6J mice
- 1 March 2015
- journal article
- research article
- Published by Wiley in Journal of the Peripheral Nervous System
- Vol. 20 (1) , 24-31
Abstract
We determined the impact diet‐induced obesity (DIO) and types 1 and 2 diabetes have on peripheral neuropathy with emphasis on corneal nerve structural changes in C57Bl/6J mice. Endpoints examined included nerve conduction velocity, response to thermal and mechanical stimuli and innervation of the skin and cornea. DIO mice and to a greater extent type 2 diabetic mice were insulin resistant. DIO and both types 1 and 2 diabetic mice developed motor and sensory nerve conduction deficits. In the cornea of DIO and type 2 diabetic mice there was a decrease in sub‐epithelial corneal nerves, innervation of the corneal epithelium, and corneal sensitivity. Type 1 diabetic mice did not present with any significant changes in corneal nerve structure until after 20 weeks of hyperglycemia. DIO and type 2 diabetic mice developed corneal structural damage more rapidly than type 1 diabetic mice although hemoglobin A1C values were significantly higher in type 1 diabetic mice. This suggests that DIO with or without hyperglycemia contributes to development and progression of peripheral neuropathy and nerve structural damage in the cornea.Keywords
Funding Information
- Department of Veterans Affairs
- Veterans Health Administration
- Office of Research and Development
- Biomedical Laboratory Research and Development Service (BX001680-01, MAY)
- Rehabilitation Research and Development Service (RX000889-01, MAY)
- Iowa City VA Center of Excellence for the Prevention and Treatment of Visual Loss (C9251-C(RHK))
- National Institute of Diabetes and Digestive and Kidney Diseases (DK081147 (MAY))
This publication has 37 references indexed in Scilit:
- Animal Models of Diabetic Neuropathy: Progress Since 1960sJournal of Diabetes Research, 2013
- Animal Models of Peripheral NeuropathiesNeurotherapeutics, 2012
- Changes in Corneal Innervation and Sensitivity and Acetylcholine-Mediated Vascular Relaxation of the Posterior Ciliary Artery in a Type 2 Diabetic RatInvestigative Ophthalmology & Visual Science, 2012
- Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosisAtherosclerosis, 2011
- Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complicationsEuropean Journal of Pharmacology, 2011
- Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J miceNeuropharmacology, 2011
- Anti-diabetic effects of emodin involved in the activation of PPARγ on high-fat diet-fed and low dose of streptozotocin-induced diabetic miceFitoterapia, 2010
- Skeletal changes associated with the onset of type 2 diabetes in the ZDF and ZDSD rodent modelsAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- The mechanisms of alloxan- and streptozotocin-induced diabetesDiabetologia, 2007
- Animal models of diabetes mellitusDiabetic Medicine, 2005